Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase Ii study
Izbicki, R.M.; Amer, M.H.; Al-Sarraf, M.
Cancer Treatment Reports 63(6): 999-1001
1979
ISSN/ISBN: 0361-5960 PMID: 380805 Document Number: 142637
A prospective trial of Adriamycin and cyclophosphamide was undertaken in the treatment of patients with hormonally refractory prostatic carcinoma. Of the 20 patients evaluable, three (15%) had a partial remission and five (25%) had stable disease for a total response of 40%. All patients who responded had subjective improvement consisting of weight gain (greater than or equal to 10% of body weight), improvement of performance status (greater than or equal 10% in Karnofsky index), and a decreased need for pain medication.
Document emailed within 1 workday
Related Documents
Abeloff, M.D.; Ettinger, D.S. 1977: Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy Cancer Treatment Reports 61(9): 1685-1689Herman, T.S.; Jones, S.E.; McMahon, L.J.; Lloyd, R.E.; Heusinkveld, R.S.; Miller, R.C.; Salmon, S.E. 1977: Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung Cancer Treatment Reports 61(5): 875-879
Denefrio, J.M.; Kaplan, R.S.; Eisenberger, M.A.; Lessner, H.E. 1981: Phase Ii study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum Cancer Treatment Reports 65(1-2): 163-164
Rodriguez, L.H.; Johnson, D.E.; Holoye, P.Y.; Samuels, M.L. 1977: Combination VM-26 and adriamycin for metastatic transitional cell carcinoma Cancer Treatment Reports 61(1): 87-88
Fraile, R.J.; Samson, M.K.; Baker, L.H.; Talley, R.W. 1979: Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung Cancer Treatment Reports 63(11-12): 1983-1987
Alberts, D.S.; Ignoffo, R. 1978: Adriamycin-cyclophosphamide treatment of squamous cell carcinoma of the cervix Cancer Treatment Reports 62(1): 143-144
Vogelzang, N.J.; Bonomi, P.D.; Rossof, A.H.; Wolter, J. 1978: Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma Cancer Treatment Reports 62(10): 1595-1597
Barzacchi, M.C.; Nobile, M.T.; Sanguineti, O.; Sertoli, M.R.; Chiara, S.; Repetto, L.; Forno, G.; Lavarello, A.; Rosso, R. 1994: Treatment of metastatic colorectal carcinoma with lymphoblastoid interferon and 5-fluorouracil: data of a phase Ii study Anticancer Research 14(5b): 2147-2149
Amrein, P.C.; Coleman, M.; Richards, F.; Bhardwaj, S.; Kennedy, B.J.; Haurani, F.I.; Frelick, R.W.; Pastmantier, M.W.; Herschkopf, R. 1984: Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase Ii study Cancer Treatment Reports 68(11): 1397-1398
Sulkes, A.; Uziely, B.; Isacson, R.; Brufman, G.; Biran, S. 1988: Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas Israel Journal of Medical Sciences 24(9-10): 604-610
Arai, Y.; Kido, C.; Endo, T.; Aoki, T. 1987: Preliminary results of a phase Ii study of 5-FU, adriamycin, and mitomycin C (FAM) in combined hepatic infusion in patients with non-resectable metastatic liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(7): 2327-2333
Hoshino, M.; Koyama, Y.; Sugano, K.; Kanno, M.; Satou, N.; Abe, R. 1989: Enhanced effect of hepatic arterial infused anticancer drugs on rabbit VX-2 carcinoma by means of combination with Lipiodol. Adriamycin versus Lipiodol adriamycin sandwich method and adriamycin suspended in a Lipiodol Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(8 Part 2): 2810-2813
Lehnert, M.; Biffl, G.; Wascher, H.; Jordis-Lohausen, K.; Wählby, S. 1986: A preliminary analysis of combination therapy with vincristine, adriamycin, and prednimustine (VAP) in advanced breast cancer: a phase Ii study Seminars in Oncology 13(1 Suppl 1: 32-34
Sörenson, S.; Hansen, H.H.; Dombernowsky, P. 1976: Phase Ii study of vinblastine, adriamycin, and procarbazine in small cell carcinoma of the lung Cancer Treatment Reports 60(9): 1263-1266
Pisoni, M.B.; Libretti, A.; Piazza, E.; Vago, G.; Scapaticci, R.; Bianchi, C.; Tomirotti, M.; Scanni, A.; Calzavara, M.P.; Cassani, L.; Scarpazza, G.; Marsoni, S.; Morasca, L. 1981: Phase Ii study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma Cancer Treatment Reports 65(7-8): 731-732
Abe, O.; Izuo, M.; Enomoto, K.; Kubo, K.; Koyama, H.; Sakai, K.; Terasawa, T.; Tominaga, T.; Nomura, Y. 1982: Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(5): 866-873
Mori, O.; Takagi, K.; Kitagawa, T.; Harada, M.; Ogawa, I. 1986: Combination chemotherapy with vincristin, actinomycin D, cyclophosphamide and adriamycin in soft-part sarcoma Gan no Rinsho. Japan Journal of Cancer Clinics 32(9): 998-1004
Rahman, Z.; Champlin, R.; Rondon, G.; Frye, D.; Valero, V.; Mehra, R.; Hortobagyi, G. 1997: Phase I/Ii study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer Seminars in Oncology 24(5 Suppl 17: S17
Bruckner, H.W.; Deppe, G. 1977: Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate Obstetrics and Gynecology 50(1 Suppl): 10s-12s
Vogl, S.E.; Berenzweig, M.; Kaplan, B.H.; Moukhtar, M.; Bulkin, W. 1979: The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) Cancer Treatment Reports 63(2): 311-317